Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/ASO.2006.05.022
Annals of Surgical Oncology 13:745-752 (2006)
© 2006 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plaza, C. P. R.
Right arrow Articles by de la Fuente Perucho, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plaza, C. P. R.
Right arrow Articles by de la Fuente Perucho, A.

Original Article

Management of Well-Differentiated Thyroglossal Remnant Thyroid Carcinoma: Time To Close the Debate? Report of Five New Cases and Proposal of a Definitive Algorithm for Treatment

César P. Ramírez Plaza, MD1, Marta E. Domínguez López, PhD2, Carmen Eloy-García Carrasco, PhD3, Luis Martínez Meseguer, PhD1 and Agustín de la Fuente Perucho, MD1

1 Department of Digestive and General Surgery, Regional University Hospital of Málaga "Carlos Haya," Avenida de Carlos Haya s/n. C.P. 29010, Málaga, Spain
2 Clinical Nutrition and Endocrinology Service, Regional University Hospital of Málaga "Carlos Haya," Avenida de Carlos Haya s/n. C.P. 29010, Málaga, Spain
3 Anatomical Pathology Service, Regional University Hospital of Málaga "Carlos Haya," Avenida de Carlos Haya s/n. C.P. 29010, Málaga, Spain

Correspondence: Address correspondence and reprint requests to: César P. Ramírez Plaza, MD; E-mail: cprptot{at}hotmail.com.

Background: Thyroid carcinoma is diagnosed in approximately 1% to 2% of thyroglossal duct remnants (TGDR). No definite agreement exists concerning the management of TGDR carcinoma, especially regarding the role of total thyroidectomy and postoperative adjuvant therapy. We report five new cases of TGDR carcinoma and review relevant articles in an attempt to clarify this issue.

Methods: We studied the demographic, clinical, tumor-related, treatment, pathologic, and outcome data on five patients treated at our institution for a TGDR carcinoma and compared the results with the four most important series published.

Results: All five patients were women, and diagnosis occurred after surgery in four. The sizes of the papillary tumors were 40, 38, 25, 23, and 15 mm (mean, 28.2 mm; range, 15–40 mm). Fine-needle aspiration biopsy of the TGDR had a low sensitivity (positive for one in four). A Sistrunk procedure was performed for resection of the TGDR in four patients, and plain TGDR resection was performed for the other patient. Three patients underwent repeat surgery; total thyroidectomy was performed in all cases, and cervical bilateral node dissection was performed in one case. With a median follow-up of 123.8 months (range, 8–284 months), all the patients are alive and free of disease, with no recurrences.

Conclusions: TGDR carcinoma is a rare malignant tumor that is usually diagnosed after surgery; papillary carcinoma is the most common type. The currently recommended treatment is a Sistrunk procedure, with a tendency to deferred total thyroidectomy in selected cases (similar criteria exist for papillary carcinoma of the thyroid gland). The prognosis is excellent, with a good long-term survival.

Key Words: Thyroglossal duct remnant • Papillary carcinoma • Thyroglossal carcinoma • Algorithm






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society of Surgical Oncology.